Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Craig Jordan

Showing results (201-210 of 218) with videos related to

Pageof 22
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 23, 2010
Experimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: a potential clinical application of angiogenesis inhibitorsRoshani R Patel, Surojeet Sengupta, Helen R Kim, et al.
Cancer Research|May 25, 2013
c-Src modulates estrogen-induced stress and apoptosis in estrogen-deprived breast cancer cellsPing Fan, Obi L Griffith, Fadeke A Agboke, et al.
International Journal of Oncology|July 3, 2010
Raloxifene-stimulated experimental breast cancer with the paradoxical actions of estrogen to promote or prevent tumor growth: a unifying concept in anti-hormone resistanceGregor M Balaburski, Rita C Dardes, Michael Johnson, et al.
Molecular Cancer Therapeutics|September 11, 2014
Novel selective estrogen mimics for the treatment of tamoxifen-resistant breast cancerMary Ellen Molloy, Bethany E Perez White, Teshome Gherezghiher, et al.
International Journal of Oncology|January 17, 2009
Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancerYoko Tabuchi, Junji Matsuoka, Mehmet Gunduz, et al.
Molecular Pharmacology|May 10, 2018
Endoxifen, 4-Hydroxytamoxifen and an Estrogenic Derivative Modulate Estrogen Receptor Complex Mediated Apoptosis in Breast CancerPhilipp Y Maximov, Balkees Abderrahman, Sean W Fanning, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 7, 2006
Emerging principles for the development of resistance to antihormonal therapy: implications for the clinical utility of fulvestrantEric A Ariazi, Joan S Lewis-Wambi, Shaun D Gill, et al.
Breast Cancer Research : BCR|May 30, 2023
Progesterone from ovulatory menstrual cycles is an important cause of breast cancerHerjan J T Coelingh Bennink, Iman J Schultz, Marcus Schmidt, et al.
Cancer Research|January 21, 2010
The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cellsEric A Ariazi, Eugen Brailoiu, Smitha Yerrum, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 10, 2009
Estrogen promotes the survival and pulmonary metastasis of tuberin-null cellsJane J Yu, Victoria A Robb, Tasha A Morrison, et al.
Pageof 22

Showing results (201-210 of 218) with videos related to

Sort By:
Pageof 22
European Journal of Cancer (Oxford, England : 1990)|March 23, 2010
Experimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: a potential clinical application of angiogenesis inhibitorsRoshani R Patel, Surojeet Sengupta, Helen R Kim, et al.
Cancer Research|May 25, 2013
c-Src modulates estrogen-induced stress and apoptosis in estrogen-deprived breast cancer cellsPing Fan, Obi L Griffith, Fadeke A Agboke, et al.
International Journal of Oncology|July 3, 2010
Raloxifene-stimulated experimental breast cancer with the paradoxical actions of estrogen to promote or prevent tumor growth: a unifying concept in anti-hormone resistanceGregor M Balaburski, Rita C Dardes, Michael Johnson, et al.
Molecular Cancer Therapeutics|September 11, 2014
Novel selective estrogen mimics for the treatment of tamoxifen-resistant breast cancerMary Ellen Molloy, Bethany E Perez White, Teshome Gherezghiher, et al.
International Journal of Oncology|January 17, 2009
Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancerYoko Tabuchi, Junji Matsuoka, Mehmet Gunduz, et al.
Molecular Pharmacology|May 10, 2018
Endoxifen, 4-Hydroxytamoxifen and an Estrogenic Derivative Modulate Estrogen Receptor Complex Mediated Apoptosis in Breast CancerPhilipp Y Maximov, Balkees Abderrahman, Sean W Fanning, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 7, 2006
Emerging principles for the development of resistance to antihormonal therapy: implications for the clinical utility of fulvestrantEric A Ariazi, Joan S Lewis-Wambi, Shaun D Gill, et al.
Breast Cancer Research : BCR|May 30, 2023
Progesterone from ovulatory menstrual cycles is an important cause of breast cancerHerjan J T Coelingh Bennink, Iman J Schultz, Marcus Schmidt, et al.
Cancer Research|January 21, 2010
The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cellsEric A Ariazi, Eugen Brailoiu, Smitha Yerrum, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 10, 2009
Estrogen promotes the survival and pulmonary metastasis of tuberin-null cellsJane J Yu, Victoria A Robb, Tasha A Morrison, et al.
Pageof 22